Commonwealth Equity Services, LLC Abbott Laboratories Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 872,054 shares of ABT stock, worth $101 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

872,054

Previous 883,617 1.31%

Holding current value

$101 Million

Previous $91.8 Million 8.28%

% of portfolio

0.15%

Previous 0.15%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$100.07 - $118.13 $1.16 Million - $1.37 Million	-11,563 Reduced 1.31%	872,054 $99.4 Million
Q2 2024 Jul 31, 2024	BUY	$100.73 - $112.44 $387,105 - $432,106	3,843 Added 0.44%	883,617 $91.8 Million
Q1 2024 Apr 29, 2024	SELL	$109.52 - $120.96 $103,715 - $114,549	-947 Reduced 0.11%	879,774 $100 Million
Q4 2023 Feb 06, 2024	BUY	$90.19 - $110.4 $1.41 Million - $1.72 Million	15,609 Added 1.8%	880,721 $96.9 Million
Q3 2023 Oct 23, 2023	SELL	$95.53 - $114.62 $1.06 Million - $1.27 Million	-11,059 Reduced 1.26%	865,112 $83.8 Million
Q2 2023 Aug 10, 2023	SELL	$100.78 - $112.29 $3.75 Million - $4.18 Million	-37,230 Reduced 4.08%	876,171 $95.5 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $1.94 Million - $2.29 Million	20,067 Added 2.25%	913,401 $92.5 Million
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $950,695 - $1.12 Million	10,001 Added 1.13%	893,334 $98.1 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $1.53 Million - $1.77 Million	15,767 Added 1.82%	883,333 $85.5 Million
Q2 2022 Jul 19, 2022	BUY	$102.07 - $123.37 $3.87 Million - $4.68 Million	37,951 Added 4.57%	867,566 $94.3 Million
Q1 2022 May 04, 2022	BUY	$114.02 - $139.04 $2.08 Million - $2.54 Million	18,256 Added 2.25%	829,615 $98.2 Million
Q4 2021 Jan 31, 2022	BUY	$115.53 - $141.46 $2.01 Million - $2.46 Million	17,423 Added 2.19%	811,359 $114 Million
Q3 2021 Oct 29, 2021	BUY	$116.66 - $129.06 $2.76 Million - $3.05 Million	23,625 Added 3.07%	793,936 $93.8 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $7.4 Million - $8.71 Million	69,924 Added 9.98%	770,311 $89.3 Million
Q1 2021 May 04, 2021	SELL	$108.84 - $128.23 $1.58 Million - $1.86 Million	-14,542 Reduced 2.03%	700,387 $83.9 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $1.85 Million - $2.02 Million	17,636 Added 2.53%	714,929 $78.3 Million
Q3 2020 Nov 05, 2020	SELL	$91.64 - $111.29 $1.26 Million - $1.53 Million	-13,774 Reduced 1.94%	697,293 $75.9 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $7.63 Million - $9.77 Million	99,710 Added 16.31%	711,067 $65 Million
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $1.37 Million - $2 Million	21,793 Added 3.7%	611,357 $48.2 Million
Q4 2019 Feb 05, 2020	BUY	$78.51 - $87.4 $2.01 Million - $2.24 Million	25,606 Added 4.54%	589,564 $51.2 Million
Q3 2019 Oct 30, 2019	BUY	$81.84 - $88.74 $1.03 Million - $1.11 Million	12,554 Added 2.28%	563,958 $47.2 Million
Q2 2019 Jul 19, 2019	SELL	$72.88 - $85.0 $634,274 - $739,755	-8,703 Reduced 1.55%	551,404 $46.4 Million
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $748,153 - $904,517	11,298 Added 2.06%	560,107 $44.8 Million
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $7.09 Million - $8.03 Million	-108,173 Reduced 16.47%	548,809 $39.7 Million
Q3 2018 Nov 06, 2018	BUY	$60.81 - $73.36 $679,247 - $819,431	11,170 Added 1.73%	656,982 $48.2 Million
Q2 2018 Jul 31, 2018	BUY	$57.57 - $63.54 $829,756 - $915,802	14,413 Added 2.28%	645,812 $39.4 Million
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $993,671 - $1.12 Million	17,659 Added 2.88%	631,399 $37.8 Million
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $32.9 Million - $35.3 Million	613,740	613,740 $35 Million

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Abbott Laboratories Transaction History